MX2012000166A - Compuestos de quinazolina que contienen fosforo y metodos de uso de los mismos. - Google Patents
Compuestos de quinazolina que contienen fosforo y metodos de uso de los mismos.Info
- Publication number
- MX2012000166A MX2012000166A MX2012000166A MX2012000166A MX2012000166A MX 2012000166 A MX2012000166 A MX 2012000166A MX 2012000166 A MX2012000166 A MX 2012000166A MX 2012000166 A MX2012000166 A MX 2012000166A MX 2012000166 A MX2012000166 A MX 2012000166A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- methods
- phosphorus containing
- cancer
- quinazoline compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052698 phosphorus Inorganic materials 0.000 title abstract 2
- 239000011574 phosphorus Substances 0.000 title abstract 2
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 239000003909 protein kinase inhibitor Substances 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
- C07F9/65685—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine oxide or thioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22255109P | 2009-07-02 | 2009-07-02 | |
| PCT/US2010/001897 WO2011002523A1 (en) | 2009-07-02 | 2010-07-02 | Phosphorus containing quinazoline compounds and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012000166A true MX2012000166A (es) | 2012-04-02 |
Family
ID=43411348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012000166A MX2012000166A (es) | 2009-07-02 | 2010-07-02 | Compuestos de quinazolina que contienen fosforo y metodos de uso de los mismos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8987284B2 (enExample) |
| EP (1) | EP2448409A4 (enExample) |
| JP (1) | JP5721709B2 (enExample) |
| KR (1) | KR20120090025A (enExample) |
| CN (1) | CN102711472B (enExample) |
| AU (1) | AU2010266725A1 (enExample) |
| BR (1) | BRPI1015363A2 (enExample) |
| CA (1) | CA2804190A1 (enExample) |
| IL (1) | IL217222A0 (enExample) |
| MX (1) | MX2012000166A (enExample) |
| RU (1) | RU2012103492A (enExample) |
| SG (1) | SG177451A1 (enExample) |
| WO (1) | WO2011002523A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1015363A2 (pt) | 2009-07-02 | 2015-08-25 | Newgen Therapeutics Inc | Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit |
| US8916574B2 (en) | 2009-09-28 | 2014-12-23 | Qilu Pharmaceutical Co., Ltd. | 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors |
| CA2875025C (en) | 2011-05-31 | 2021-08-03 | Newgen Therapeutics, Inc. | Tricyclic inhibitors of poly(adp-ribose)polymerase |
| CN103772411B (zh) * | 2013-04-28 | 2016-08-03 | 复旦大学 | 含硫6-呋喃基喹唑啉-4-胺化合物及其制备方法和用途 |
| CN104610364B (zh) * | 2015-01-30 | 2017-03-29 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558042B (zh) * | 2015-01-30 | 2017-03-29 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558043B (zh) * | 2015-01-30 | 2017-01-11 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558041B (zh) * | 2015-01-30 | 2017-01-11 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558040B (zh) * | 2015-01-30 | 2017-04-05 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的晶型及其制备方法和应用 |
| CN105388242A (zh) * | 2015-11-11 | 2016-03-09 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼原料药中残留溶剂的检测方法 |
| CN105424831B (zh) * | 2015-11-11 | 2017-11-10 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼原料药中有效成分的定量检测方法 |
| CN105606717B (zh) * | 2015-11-11 | 2017-10-24 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼原料药中有关物质的检测方法 |
| CN105237573B (zh) * | 2015-11-11 | 2017-10-24 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼的制备方法 |
| CN108285421A (zh) * | 2018-01-26 | 2018-07-17 | 黑龙江鑫创生物科技开发有限公司 | 一种微通道反应器合成拉帕替尼中间体的方法 |
| CN119390683A (zh) | 2019-08-15 | 2025-02-07 | 黑钻治疗公司 | 炔基喹唑啉化合物 |
| CN113995728B (zh) * | 2020-07-28 | 2023-03-14 | 江苏康缘药业股份有限公司 | 一种药物组合物及制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0912559B1 (en) | 1996-07-13 | 2002-11-06 | Glaxo Group Limited | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| TR200102505T2 (tr) | 1999-02-27 | 2003-01-21 | Boehringer Ingelheim Pharma Kg | 4-amino-kinazolin ve kinolin türevleri. |
| DE19911509A1 (de) | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| JP2003504363A (ja) | 1999-07-09 | 2003-02-04 | グラクソ グループ リミテッド | プロテインチロシンキナーゼ阻害剤としてのアニリノキナゾリン類 |
| US6894057B2 (en) | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| DE10217689A1 (de) | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| EA008775B1 (ru) * | 2002-04-26 | 2007-08-31 | Джилид Сайэнс, Инк. | Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция |
| WO2004046101A2 (en) | 2002-11-20 | 2004-06-03 | Array Biopharma, Inc. | Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| US7223749B2 (en) | 2003-02-20 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| DE10307165A1 (de) | 2003-02-20 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| DE10349113A1 (de) | 2003-10-17 | 2005-05-12 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Aminocrotonylverbindungen |
| EP1682123A1 (en) | 2003-11-07 | 2006-07-26 | SmithKline Beecham (Cork) Limited | Cancer treatment method |
| WO2005105094A2 (en) | 2004-04-16 | 2005-11-10 | Smithkline Beecham Corporation | Cancer treatment method |
| CN101421269A (zh) | 2006-01-13 | 2009-04-29 | 环状药物公司 | 酪氨酸激酶抑制剂及其用途 |
| JP5241513B2 (ja) | 2006-01-26 | 2013-07-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アミノクロトニルアミノ置換キナゾリン誘導体の合成方法 |
| US20080234267A1 (en) * | 2007-03-20 | 2008-09-25 | Karen Elizabeth Lackey | Compounds and Methods of Treatment |
| BRPI1015363A2 (pt) | 2009-07-02 | 2015-08-25 | Newgen Therapeutics Inc | Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit |
-
2010
- 2010-07-02 BR BRPI1015363-2A patent/BRPI1015363A2/pt not_active IP Right Cessation
- 2010-07-02 CA CA2804190A patent/CA2804190A1/en not_active Abandoned
- 2010-07-02 CN CN201080039138.2A patent/CN102711472B/zh active Active
- 2010-07-02 AU AU2010266725A patent/AU2010266725A1/en not_active Abandoned
- 2010-07-02 KR KR1020127002859A patent/KR20120090025A/ko not_active Withdrawn
- 2010-07-02 SG SG2011097581A patent/SG177451A1/en unknown
- 2010-07-02 RU RU2012103492/04A patent/RU2012103492A/ru not_active Application Discontinuation
- 2010-07-02 MX MX2012000166A patent/MX2012000166A/es not_active Application Discontinuation
- 2010-07-02 US US13/380,808 patent/US8987284B2/en active Active
- 2010-07-02 EP EP10794499.3A patent/EP2448409A4/en not_active Withdrawn
- 2010-07-02 WO PCT/US2010/001897 patent/WO2011002523A1/en not_active Ceased
- 2010-07-02 JP JP2012517506A patent/JP5721709B2/ja active Active
-
2011
- 2011-12-27 IL IL217222A patent/IL217222A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8987284B2 (en) | 2015-03-24 |
| RU2012103492A (ru) | 2013-08-10 |
| CA2804190A1 (en) | 2011-01-06 |
| HK1176519A1 (zh) | 2013-08-02 |
| CN102711472A (zh) | 2012-10-03 |
| US20120196833A1 (en) | 2012-08-02 |
| WO2011002523A1 (en) | 2011-01-06 |
| EP2448409A4 (en) | 2013-04-10 |
| CN102711472B (zh) | 2015-12-02 |
| BRPI1015363A2 (pt) | 2015-08-25 |
| KR20120090025A (ko) | 2012-08-16 |
| JP2012532100A (ja) | 2012-12-13 |
| JP5721709B2 (ja) | 2015-05-20 |
| IL217222A0 (en) | 2012-02-29 |
| AU2010266725A1 (en) | 2012-02-23 |
| SG177451A1 (en) | 2012-02-28 |
| EP2448409A1 (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012000166A (es) | Compuestos de quinazolina que contienen fosforo y metodos de uso de los mismos. | |
| UA99141C2 (ru) | Замещенные производные индазола, активные в качестве ингибиторов киназы | |
| MX336051B (es) | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. | |
| EA026155B9 (ru) | Макроциклические производные для лечения пролиферативных заболеваний | |
| MX2010006739A (es) | Compuestos pirido[2,3-b]pirazina-8-sustituidos y su uso. | |
| EA201200618A1 (ru) | Производные хроменона с антиопухолевой активностью | |
| MX2010007714A (es) | Piridinas fusionadas activas como inhibidores de c-met. | |
| MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| MY189427A (en) | Pyrazolyl quinoxaline kinase inhibitors | |
| MY159615A (en) | Fused heterocyclic derivatives and methods of use as c-met inhibitors | |
| MX2009009592A (es) | Aminopiridinas utiles como inhibidores de proteinas cinasas. | |
| SI2324008T1 (sl) | 3,4-diarilpirazoli kot protein-kinazni inhibitorji | |
| EA201201161A1 (ru) | Пирролопиримидины в качестве ингибиторов cdk4/6 | |
| MX2013012588A (es) | Inhibidores de cinasa. | |
| PH12013501758A1 (en) | Pyrazolo [1,5-a] pyridines as trk inhibitors | |
| MX2013001361A (es) | 4-(1h-indol-3-il) - pirimidina como inhibidores de alk. | |
| MX342873B (es) | Derivados de pirazolo-quinazolina sustituidos como inhibidores de cinasa. | |
| WO2009036996A3 (en) | Small molecule bradykinin b1 receptor antagonists | |
| PH12012500622A1 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| AU2009282962A8 (en) | Compounds as kinase inhibitors | |
| MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
| EA201390520A1 (ru) | Замещенные соединения пиридазинкарбоксамида | |
| MX2014000964A (es) | Derivados aza heterociclicos sustituidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |